In last trading session, Citius Pharmaceuticals Inc (NASDAQ:CTXR) saw 2.85 million shares changing hands with its beta currently measuring 0.98. Company’s recent per share price level of $1.2 trading at -$0.09 or -6.98% at ring of the bell on the day assigns it a market valuation of $13.41M. That closing price of CTXR’s stock is at a discount of -2087.5% from its 52-week high price of $26.25 and is indicating a premium of 45.83% from its 52-week low price of $0.65.
For Citius Pharmaceuticals Inc (CTXR), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.67. Splitting up the data highlights that, out of 1 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 1 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Citius Pharmaceuticals Inc (NASDAQ:CTXR) trade information
Upright in the red during last session for losing -6.98%, in the last five days CTXR remained trading in the green while hitting it’s week-highest on Wednesday, 06/25/25 when the stock touched $1.2 price level, adding 17.24% to its value on the day. Citius Pharmaceuticals Inc’s shares saw a change of -92.12% in year-to-date performance and have moved 40.63% in past 5-day. Citius Pharmaceuticals Inc (NASDAQ:CTXR) showed a performance of 70.70% in past 30-days.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 20.90% during past 5 years.
Citius Pharmaceuticals Inc (NASDAQ:CTXR)’s Major holders
ARMISTICE CAPITAL, LLC is the top institutional holder at CTXR for having 10.16 million shares of worth $5.93 million. And as of 2024-06-30, it was holding 6.3845 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 6.33 million shares on 2024-06-30. The number of shares represents firm’s hold over 3.9776 of outstanding shares, having a total worth of $3.69 million.
